4 research outputs found
Synthesis of Highly Substituted 4<i>H</i>‑Pyrido[1,2‑<i>a</i>]pyrimidines via a One-Pot Three-Component Condensation Reaction
A one-pot
three-component reaction, involving condensation of 2-aminopyridines,
aldehydes, and ketones/aldehydes under trifluoromethanesulfonic acid
catalysis, provides rapid access to highly substituted novel 4<i>H</i>-pyridoÂ[1,2-<i>a</i>]Âpyrimidines
Synthesis of Highly Substituted 4<i>H</i>‑Pyrido[1,2‑<i>a</i>]pyrimidines via a One-Pot Three-Component Condensation Reaction
A one-pot
three-component reaction, involving condensation of 2-aminopyridines,
aldehydes, and ketones/aldehydes under trifluoromethanesulfonic acid
catalysis, provides rapid access to highly substituted novel 4<i>H</i>-pyridoÂ[1,2-<i>a</i>]Âpyrimidines
Single-Electron Oxidation/Alterable C3- and C10-Arylation of 9‑MeO-phenanthrene
A reactivity pattern for C3-arylation
of 9-MeO-phenanthrene has
been established for the first time by using 2-naphthyl amines as
coupling partners. A series of phenanthrene- and naphthalene-based
multifunctionalized polycyclic aromatic hydrocarbons have been obtained
in good to excellent yields. Alternative C10-arylation of 9-MeO-phenanthrene
has also been accomplished, using 2-naphthalenol derivatives as coupling
partners. Trifluoroacetic acid is found crucial for the regioselectivity.
Density functional theory calculations and electrochemical analyses
have been performed to rationalize the reaction mechanism
Discovery of Novel Tricyclic Thiazepine Derivatives as Anti-Drug-Resistant Cancer Agents by Combining Diversity-Oriented Synthesis and Converging Screening Approach
An efficient discovery strategy by
combining diversity-oriented
synthesis and converging cellular screening is described. By a three-round
screening process, we identified novel tricyclic pyridoÂ[2,3-<i>b</i>]Â[1,4]Âbenzothiazepines showing potent inhibitory activity
against paclitaxel-resistant cell line H460<sub>TaxR</sub> (EC<sub>50</sub> < 1.0 μM), which exhibits much less toxicity toward
normal cells (EC<sub>50</sub> > 100 μM against normal human
fibroblasts). The most active hits also exhibited drug-like properties
suitable for further preclinical research. This redeployment of antidepressing
compounds for anticancer applications provides promising future prospects
for treating drug-resistant tumors with fewer side effects